| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing detection and response capacities for emerging and re-emerging pathogens in Africa
|
Nachega, Jean B
|
|
|
23 |
5 |
p. e185-e189
|
artikel
|
| 2 |
A new Director for the Global Malaria Programme
|
Burki, Talha
|
|
|
23 |
5 |
p. 536-537
|
artikel
|
| 3 |
An insightful story of parasites
|
Bagcchi, Sanjeet
|
|
|
23 |
5 |
p. 544
|
artikel
|
| 4 |
Annelies Zinkernagel—Current ESCMID President
|
Kirby, Tony
|
|
|
23 |
5 |
p. 540
|
artikel
|
| 5 |
A tale of potential mpox reinfection
|
The Lancet Infectious Diseases,
|
|
|
23 |
5 |
p. 509
|
artikel
|
| 6 |
Balancing tuberculosis therapy and substance use
|
Ashley-Norman, Phoebe
|
|
|
23 |
5 |
p. 542
|
artikel
|
| 7 |
Can smallpox be called a contagion of liberty?
|
Ramgolam, Aimee
|
|
|
23 |
5 |
p. 541
|
artikel
|
| 8 |
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study
|
Fink, Douglas L
|
|
|
23 |
5 |
p. 589-597
|
artikel
|
| 9 |
Correction to Lancet Infect Dis 2023; 23: e122–37
|
|
|
|
23 |
5 |
p. e166
|
artikel
|
| 10 |
Correction to Lancet Infect Dis 2023; published online March 15. https://doi.org/10.1016/S1473-3099(23)00180-9
|
|
|
|
23 |
5 |
p. e166
|
artikel
|
| 11 |
Diagnostic capacity for invasive fungal infections in advanced HIV disease in Africa: a continent-wide survey
|
Lakoh, Sulaiman
|
|
|
23 |
5 |
p. 598-608
|
artikel
|
| 12 |
Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab
|
Solera, Javier T
|
|
|
23 |
5 |
p. 528-530
|
artikel
|
| 13 |
DNDi receives Dutch funding boost
|
Bagcchi, Sanjeet
|
|
|
23 |
5 |
p. 535
|
artikel
|
| 14 |
Effects of social norm feedback on antibiotic prescribing and its characteristics in behaviour change techniques: a mixed-methods systematic review
|
Zeng, Yingchao
|
|
|
23 |
5 |
p. e175-e184
|
artikel
|
| 15 |
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1
|
Uraki, Ryuta
|
|
|
23 |
5 |
p. 525-526
|
artikel
|
| 16 |
Emil Gotschlich
|
Bagcchi, Sanjeet
|
|
|
23 |
5 |
p. 539
|
artikel
|
| 17 |
How have infectious diseases shaped today's global health?
|
Adhikari, Bipin
|
|
|
23 |
5 |
p. 543
|
artikel
|
| 18 |
Human rabies despite post-exposure prophylaxis: a systematic review of fatal breakthrough infections after zoonotic exposures
|
Whitehouse, Erin R
|
|
|
23 |
5 |
p. e167-e174
|
artikel
|
| 19 |
Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia
|
Fadlyana, Eddy
|
|
|
23 |
5 |
p. 545-555
|
artikel
|
| 20 |
Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial
|
Adigweme, Ikechukwu
|
|
|
23 |
5 |
p. 609-620
|
artikel
|
| 21 |
Increased choices of pneumococcal vaccines for policy makers
|
Slotved, Hans-Christian
|
|
|
23 |
5 |
p. 519-520
|
artikel
|
| 22 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
23 |
5 |
p. 537
|
artikel
|
| 23 |
International platform trials: as diseases cross borders, so should trials
|
Saito, Hiroki
|
|
|
23 |
5 |
p. 530-531
|
artikel
|
| 24 |
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial
|
Lyke, Kirsten E
|
|
|
23 |
5 |
p. 578-588
|
artikel
|
| 25 |
Malaria outbreak in Laos caused by formerly rare artemisinin resistant strains of Plasmodium falciparum
|
Barry, Alyssa E
|
|
|
23 |
5 |
p. 513-514
|
artikel
|
| 26 |
Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis
|
Wasakul, Varanya
|
|
|
23 |
5 |
p. 568-577
|
artikel
|
| 27 |
Marburg virus outbreak in Equatorial Guinea
|
Samarasekera, Udani
|
|
|
23 |
5 |
p. 534
|
artikel
|
| 28 |
Monoclonals against malaria: the promise of passive protection
|
Smit, Merel J
|
|
|
23 |
5 |
p. 514-516
|
artikel
|
| 29 |
Mpox: a new name for a new disease?
|
Beaumont, Anne-Lise
|
|
|
23 |
5 |
p. 516-517
|
artikel
|
| 30 |
Novel severe oculocutaneous manifestations of human monkeypox virus infection and their historical analogues
|
Carrubba, Steven
|
|
|
23 |
5 |
p. e190-e197
|
artikel
|
| 31 |
Pragmatic trials to inform policy decisions and planning
|
Bar-Zeev, Naor
|
|
|
23 |
5 |
p. 510-511
|
artikel
|
| 32 |
Promising efforts to develop an mRNA vaccine against Zika
|
Wilder-Smith, Annelies
|
|
|
23 |
5 |
p. 520-522
|
artikel
|
| 33 |
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
|
Bobrovitz, Niklas
|
|
|
23 |
5 |
p. 556-567
|
artikel
|
| 34 |
Research in brief
|
Devi, Sharmila
|
|
|
23 |
5 |
p. 538
|
artikel
|
| 35 |
Risk of omicron infection for high-risk older adults in long-term care facilities
|
Pallett, Scott J C
|
|
|
23 |
5 |
p. 526-527
|
artikel
|
| 36 |
SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster
|
Wang, Qian
|
|
|
23 |
5 |
p. 527-528
|
artikel
|
| 37 |
Staphylococcal scalded skin syndrome in a child
|
Qian, Qinwei
|
|
|
23 |
5 |
p. 634
|
artikel
|
| 38 |
Successful tuberculosis treatment in Ukraine
|
Holt, Ed
|
|
|
23 |
5 |
p. 533
|
artikel
|
| 39 |
Tecovirimat concentrations and viral suppression in seminal fluid from patients with mpox
|
Tempestilli, Massimo
|
|
|
23 |
5 |
p. 531-532
|
artikel
|
| 40 |
The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
|
Boaventura, Viviane S
|
|
|
23 |
5 |
p. 511-512
|
artikel
|
| 41 |
The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials
|
Essink, Brandon
|
|
|
23 |
5 |
p. 621-633
|
artikel
|
| 42 |
The urgent need to scale-up fungal diagnostics in Africa
|
Osaigbovo, Iriagbonse Iyabo
|
|
|
23 |
5 |
p. 517-519
|
artikel
|
| 43 |
Two individuals with potential monkeypox virus reinfection
|
Raccagni, Angelo Roberto
|
|
|
23 |
5 |
p. 522-524
|
artikel
|
Tijdschrift beschrijving